Statement of Principles concerning polycythaemia vera No. 78 of 1999

Administered by Department of Veterans' Affairs

Legislation au F2005B02438 Not in force Legislative Instrument

Legislation content

 

Statement of Principles

concerning

POLYCYTHAEMIA VERA

Instrument No. 78 of 1999 as amended

made under section 196B(2) of the

Veterans’ Entitlements Act 1986

This compilation was prepared on 3 October 2005
taking into account Amendment of Statement of Principles concerning POLYCYTHAEMIA VERA (Instrument No. 11 of 2000) and Amendment of Statement of Principles concerning POLYCYTHAEMIA VERA (Instrument No. 30 of 2005).

Prepared by the Repatriation Medical Authority Secretariat, Brisbane

 

Revocation and Determination

of

Statement of Principles

concerning

 

POLYCYTHAEMIA VERA

 

ICD-10-AM CODE: D45

 

Veterans’ Entitlements Act 1986

 

 

1. The Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act):

 

(a) revokes Instrument No.67 of 1995; and

 

(b) determines in its place the following Statement of Principles.

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about polycythaemia vera and death from polycythaemia vera.

 

(b)               For the purposes of this Statement of Principles, “polycythaemia vera”, also known as polycythaemia rubra vera, means a chronic myeloproliferative disorder, characterised by abnormal proliferation of haematopoietic bone marrow elements, resulting in an absolute increase in red cell mass, an excess of platelets and white blood cells, and splenomegaly, attracting ICD-10-AM code D45. This definition excludes relative polycythaemia and polycythaemia resulting from hypoxaemia.

 

Basis for determining the factors

3. After examining the available sound medical-scientific evidence the Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that the only factor that may be related to the cause of or material contribution to or aggravation of polycythaemia vera or death from polycythaemia vera and which can be related to relevant service is that set out in clause 4.

 

Factors that must be related to service

4. The factor that must as a minimum exist in relation to the circumstances of a person’s relevant service causing or materially contributing to or aggravating polycythaemia vera or death from polycythaemia vera is inability to obtain appropriate clinical management for polycythaemia vera.

 

Inclusion of Statements of Principles

5. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

6.                  For the purposes of this Statement of Principles:

 

death from polycythaemia vera” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s polycythaemia vera;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), effective date of 1 July 1998, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86451 340 3;

 

“relevant service” means:

 

(a) operational service; or

(b) peacekeeping service; or

(c) hazardous service;

 

“terminal event” means the proximate or ultimate cause of death and includes:

 

a) pneumonia;

b) respiratory failure;

c) cardiac arrest;

d) circulatory failure; or

e) cessation of brain function.

 

Application

7. This Instrument applies to all matters to which section 120A of the Act applies.


Notes to Statement of Principles concerning polycythaemia vera (Instrument No. 78 of 1999)

The Statement of Principles concerning polycythaemia vera (Instrument No. 78 of 1999) in force under section 196B(2) of the Veterans’ Entitlements Act 1986, as shown in this compilation is amended as indicated in the Tables below.

Table of Instruments

Title

Date of notification
in Gazette or FRLI registration

Date of
commencement

Application, saving or
transitional provisions

Statement of Principles concerning polycythaemia vera (Instrument No. 78 of 1999)

10 November 1999

(see Gazette 1999, No. GN 45 )

10 November 1999

 

Amendment of Statement of Principles concerning polycythaemia vera (Instrument No. 11 of 2000)

10 January 2001

(see Gazette 2001, No. GN 1 )

10 January 2001

as amended by

   Amendment of Statement of Principles concerning polycythaemia vera (Instrument No. 30 of 2005)

 

21 September 2005

(see F2005L02759)

 

28 September 2005

 

Table of Amendments

ad. = added or inserted      am. = amended      rep. = repealed      rs. = repealed and substituted

Provision affected

How affected

Clause 3 – ‘Basis for determining the factors’ 

rs. Instrument  No.11 of 2001

Clause 4 – ‘Factors that must be related to service’ 

rs. Instrument  No.11 of 2001

Clause 5 – ‘Factors’......

rep. Instrument  No.11 of 2001

Clause 6 – ‘Factors that apply only to material contribution or aggravation’ 

rep. Instrument  No.11 of 2001

Clause 5 – ‘Inclusion of Statements of Principles’ 

am. Instrument  No.11 of 2001

Clause 6 – ‘Other definitions’ 

am. Instrument  No.11 of 2001

Clause 7 – ‘Application’...

am. Instrument  No.11 of 2001

 

Overview

The Statement of Principles concerning Polycythaemia Vera (Instrument No. 78 of 1999), made under section 196B(2) of the Veterans’ Entitlements Act 1986, addresses the issue of polycythaemia vera, a chronic myeloproliferative disorder that leads to an abnormal increase in red cell mass, platelets, and white blood cells, and splenomegaly, and its relation to service in the Australian Defence Force. This legislative instrument was developed by the Repatriation Medical Authority and was enacted to provide clarity on the circumstances under which veterans may be eligible for benefits related to polycythaemia vera. The policy objective is to ensure that veterans who were unable to obtain appropriate clinical management for polycythaemia vera during their service are recognised and provided with the necessary support. The instrument has been amended over time to refine the criteria and definitions to better align with current medical understanding and the needs of affected veterans.

Scope and Application

This legislative instrument, the Statement of Principles concerning Polycythaemia Vera, made under section 196B(2) of the Veterans’ Entitlements Act 1986, outlines the criteria for determining the service-related causation of polycythaemia vera and death from polycythaemia vera among veterans. It applies to all matters to which section 120A of the Veterans’ Entitlements Act 1986 applies, effectively encompassing veterans who seek to establish a connection between their military service and the development or aggravation of polycythaemia vera. The instrument specifically addresses polycythaemia vera, a chronic myeloproliferative disorder characterised by abnormal proliferation of haematopoietic bone marrow elements, and excludes other forms of polycythaemia such as relative polycythaemia and that resulting from hypoxaemia. The key factor stipulated in the instrument is the inability to obtain appropriate clinical management for polycythaemia vera during relevant service, which must be related to the cause or aggravation of the condition. This Statement of Principles has been subject to amendments, with the latest version effective from 28 September 2005, updating the criteria and definitions to reflect the most current medical-scientific evidence.

Key Provisions

The Statement of Principles concerning Polycythaemia Vera, made under section 196B(2) of the Veterans’ Entitlements Act 1986, outlines the specific conditions under which polycythaemia vera and death from polycythaemia vera can be considered related to a veteran's service (Section 1). It defines polycythaemia vera as a chronic myeloproliferative disorder, excluding relative polycythaemia and polycythaemia resulting from hypoxaemia (Section 2). The primary factor that may relate to the cause or aggravation of polycythaemia vera in a veteran is the inability to obtain appropriate clinical management for the condition during their service (Section 4). This statement also incorporates any relevant factors from other statements of principles if they apply to the veteran's condition (Section 5). Definitions for terms such as "death from polycythaemia vera," "relevant service," and "terminal event" are provided to clarify the scope and application of the principles (Section 6). The obligations under this legislation primarily involve the Repatriation Medical Authority, which is tasked with determining whether a veteran's polycythaemia vera or death from polycythaemia vera is related to their service. This determination is based on the factors outlined in the Statement of Principles, specifically focusing on the veteran's access to appropriate clinical management during their service (Section 4). If a veteran's condition is found to be related to their service, they may be entitled to certain veterans' entitlements under the Act (Section 120A). There are no specific offences, penalties, or consequences outlined in the Statement of Principles concerning Polycythaemia Vera itself. However, any breaches of the Veterans’ Entitlements Act 1986, under which this Statement of Principles is made, may result in civil or criminal penalties as provided for in the Act. The consequences for such breaches can include fines, imprisonment, or other penalties as determined by the relevant courts. The Statement of Principles serves as a guideline for determining eligibility for veterans' entitlements based on the conditions outlined, rather than imposing penalties for non-compliance with the principles.

Legal classification tags

Area of Law
Veterans’ Entitlements
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Enforcement Powers

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.